Holen Sie sich die Stockscreener-App
1.25
3.85%
-0.05
Handel nachbörslich:
1.27
0.02
+1.60%
NanoViricides Inc Aktie (NNVC) Neueste Nachrichten
Applied Digital, Benchmark, Knowles, Cognex, and Flex Stocks Trade Down, What You Need To Know - Barchart.com
Shootin' the Bull about wait and see - Barchart.com
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
EU indefinitely freezes Russian assets to stop Moscow-friendly Hungary and Slovakia from vetoing their use for Ukraine - Barchart.com
2 Small-Cap Biotechs That Could Reward Patient Investors - MarketBeat
Is Clorox Stock Underperforming the S&P 500? - Barchart.com
Is J.B. Hunt Transport Services Stock Outperforming the Dow? - Barchart.com
Americans, including many in Trump’s base, overwhelmingly see higher holiday prices than normal, an AP-NORC poll finds - Barchart.com
Is Hologic Stock Outperforming the Nasdaq? - Barchart.com
How Is VeriSign’s Stock Performance Compared to Other Software Stocks? - Barchart.com
NanoViricides Holds 2025 Annual Stockholders Meeting - MSN
US sanctions 3 nephews of Venezuelan President Maduro as Trump further ramps up pressure on South American nation - Barchart.com
This AI Stock Has 45% Upside Potential and No One Is Talking About It Yet - Barchart.com
How Is Best Buy's Stock Performance Compared to Other Specialty Retail Stocks? - Barchart.com
Corpay Stock: Is CPAY Underperforming the Technology Sector? - Barchart.com
Omnicom Group (OMC) Stock Is Up, What You Need To Know - Barchart.com
Is Steel Dynamics Stock Outperforming the Dow? - Barchart.com
Is PTC Stock Underperforming the Nasdaq? - Barchart.com
Is Teradyne Stock Outperforming the Nasdaq? - Barchart.com
Is Cardinal Health Stock Outperforming the Nasdaq? - Barchart.com
Is FirstEnergy Stock Underperforming the S&P 500? - Barchart.com
How Is Rollins’ Stock Performance Compared to Other Cyclical Stocks? - Barchart.com
GBPUSD Extends Rally As Bullish Impulse Builds - Barchart.com
Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive - Savannah Morning News
Apple Stock Marks a Solid Comeback. Is AAPL a Buy, Sell, or Hold for 2026? - Barchart.com
NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles - Enterprise News
Why Are Revolve (RVLV) Shares Soaring Today - Barchart.com
Upwork (UPWK) Stock Is Up, What You Need To Know - Barchart.com
This Clinical-Stage Biotech Just Raised $6M to Advance a Drug That Could Address Pandemic Preparedness Gaps - Barchart.com
DiagnosTear Technologies Inc.Confirmation of No Material Change - Barchart.com
A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricidesNV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus - York Dispatch
NanoViricides Has Received Approval to Start Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo - Reuters
NanoViricides Inc Stock Analysis and ForecastGlobal Trade Effects & Free Get Breakthrough Ideas - earlytimes.in
Upstart (UPST): Buy, Sell, or Hold Post Q3 Earnings? - Barchart.com
Oracle Earnings: What To Look For From ORCL - Barchart.com
Stocks in play: Aurora Cannabis Inc. - Barchart.com
EURNZD May Have Topped - Barchart.com
3 Profitable Stocks That Fall Short - Barchart.com
NanoViricides, Inc. Has Filed its Quarterly ReportSubsequent Raise Has Fortified Fiscal Position - Victorville Daily Press
Is Monolithic Power Systems Stock Outperforming the Nasdaq? - Barchart.com
Why NanoViricides Inc. (NV3P) stock attracts wealthy investorsPortfolio Performance Report & Reliable Entry Point Trade Alerts - Newser
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - Lansing State Journal
How NanoViricides Inc. stock compares with tech leadersEarnings Risk Report & Technical Confirmation Alerts - Newser
Why institutional investors increase stakes in NanoViricides Inc. (NV3P) stockMarket Activity Report & High Accuracy Investment Signals - Newser
Can NanoViricides Inc. stock survive global slowdownWeekly Investment Report & Verified Entry Point Signals - Newser
Why Snowflake (SNOW) Shares Are Trading Lower Today - Barchart.com
NanoViricides to Present at the Spartan Capital Investor Conference 2025 in New York City Today, November 3rd - The Ames Tribune
Will NanoViricides Inc. (NV3P) stock announce a stock split2025 Dividend Review & Technical Confirmation Trade Alerts - Newser
Stocks in play: Tilray Brands, Inc. - Barchart.com
Will NanoViricides Inc. (NV3P) stock outperform energy sector in 2025Weekly Trade Review & Smart Investment Allocation Tips - Newser
How NanoViricides Inc. stock trades after earningsTrend Reversal & Reliable Trade Execution Plans - Newser
Is NanoViricides Inc. stock a buy before earnings resultsMarket Growth Report & Long-Term Capital Growth Ideas - Newser
Is NanoViricides Inc. stock a defensive play amid uncertaintyWeekly Risk Summary & Weekly High Potential Stock Alerts - Newser
Will NanoViricides Inc. (NV3P) stock profit from AI boomEarnings Miss & AI Forecast Swing Trade Picks - Newser
NanoViricides (NYSE:NNVC) Stock Price Down 8.2% – What’s Next? - Defense World
Methode: Fiscal Q2 Earnings Snapshot - Barchart.com
NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 - Gadsden Times
Why Strategy (MSTR) Stock Is Up Today - Barchart.com
Is Johnson Controls International Stock Outperforming the Nasdaq? - Barchart.com
Can NanoViricides Inc. (NV3P) stock ride next bull market cycle2025 Technical Overview & Low Volatility Stock Recommendations - Newser
Club Offers for Travel Enthusiasts in Canada - Barchart.com
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):